2026 Agenda

Cambridge VIP’s 25th Annual

Medtech MVP

Investing in Medtech’s Future through Insight and Innovation Sharing

June 1-2, 2026

Now in its 25th year, the Medtech MVP Venture & Partnering Conference continues to bring together top innovators, investors, and executives shaping the future of medical technology. Known for its candid panel discussions, fireside chats, town-hall forums, and high-value networking, Medtech MVP offers an inside look at the forces driving growth across the medtech ecosystem—from capital strategy and clinical innovation to regulatory and market dynamics.

This year’s program will explore the road ahead for smaller companies navigating a shifting economy and new administration, and spotlight emerging technologies through a dynamic pitch contest and company showcase. Additional sessions will dive into the evolving M&A vs. IPO landscape, advances in neurostimulation, the convergence of software and hardware, AI and GenAI applications in medtech, effective clinical-trial design, regulatory updates, and compelling patient stories that remind us why innovation matters.

Join industry leaders and visionaries as we celebrate 25 years of connection, collaboration, and progress—and set the stage for the next era of medtech innovation.


Coverage will include, but is not limited to:


Investment & Financial Strategy:
  • MedTech Investment Outlook: Trends, Forecasts, and Market Drivers
  • Capital-Raising Strategies for Early- and Late-Stage Companies
  • IPO vs. M&A: Choosing the Right Exit Path
The State of MedTech M&A and Investment Landscape:
  • Emerging Investment Hotspots in MedTech
  • Global and Geopolitical Forces Shaping MedTech Investing
Technology, AI & Innovation:
  • Technological Breakthroughs Redefining the Medical-Device Sector
  • AI, Agentic AI, and Generative AI: Real-World Use Cases in MedTech
  • Robotics in Medicine: From Soft Tissue to Surgical Systems
  • Digital-Health Integration: Bridging Devices, Data, and Patient Care
Regulation, Compliance & Market Access:
  • Navigating Regulatory Pathways: Insights for FDA and Global Approvals
  • Pre-Market vs. Post-Market Data: What Investors Need to Know
  • Ensuring Clinical and Commercial Success Post-Approval
  • Regulatory Strategy as a Value Driver for Investors

If you have a compelling story to share with innovators, investors, and executives attending this boutique event, we encourage you to submit a speaking proposal.

Please note that the vast majority of speakers are identified, selected, and invited by our summit chairs and advisory board members. As we receive a high volume of submissions, we regret that Cambridge VIP can only be in contact with those deemed optimal candidates.

To become a sponsor, click here.

CONFERENCE CONTENT

Ben Lakin, PhD
Chief Executive Officer
(+1) 781-972-5454
blakin@cambridgeinnovationinstitute.com

Jason Green
Senior Conference Director
jgreen@cambridgeinnovationinstitute.com

PARTNERING & SPONSORSHIP

Brian Caine
Manager, Strategic Partnerships
Venture, Innovation & Partnering (VIP) Event Series
(+1) 908-809-0946
bcaine@cambridgeinnovationinstitute.com